Decision: Favourable

Study Title:

A Phase 1/1b Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants with BRAF and/or NRAS Mutation-positive Solid Tumors

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Prof John Crown

  • PI Institution:

    St Vincent's University Hospital

  • Sponsor:

    Kinnate Biopharma Inc

Scroll to Top